214 related articles for article (PubMed ID: 27448302)
1. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
[TBL] [Abstract][Full Text] [Related]
2. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
5. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
[TBL] [Abstract][Full Text] [Related]
6. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
7. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
[TBL] [Abstract][Full Text] [Related]
8. Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer.
Chen CC; Chen HY; Su KY; Hong QS; Yan BS; Chen CH; Pan SH; Chang YL; Wang CJ; Hung PF; Yuan S; Chang GC; Chen JJ; Yang PC; Yang YC; Yu SL
Am J Respir Crit Care Med; 2014 Aug; 190(4):433-44. PubMed ID: 25036006
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
10. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
[TBL] [Abstract][Full Text] [Related]
12. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
[TBL] [Abstract][Full Text] [Related]
13. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
15. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
Zhang X; Yin Z; Li C; Nie L; Chen K
Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
[TBL] [Abstract][Full Text] [Related]
16. LINC00476 Suppresses the Progression of Non-Small Cell Lung Cancer by Inducing the Ubiquitination of SETDB1.
Cui G; Fu X; Wang W; Chen X; Liu S; Cao P; Zhao S
Radiat Res; 2021 Mar; 195(3):275-283. PubMed ID: 33370431
[TBL] [Abstract][Full Text] [Related]
17. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway.
Wang Y; Zhou J; Xu YJ; Hu HB
J Cell Physiol; 2018 Apr; 233(4):3397-3406. PubMed ID: 28926089
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway.
Fang Z; Zhong M; Zhou L; Le Y; Wang H; Fang Z
Bioengineered; 2022 Mar; 13(3):6807-6818. PubMed ID: 35246020
[TBL] [Abstract][Full Text] [Related]
20. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
